Clinical Trials
4 trialsNCT05201404 2025-04-29
LIVERATION
Can-Fite BioPharma
Phase 3 Recruiting
NCT02232490 2019-02-26
Hepko-V5
Immunitor LLC
Phase 3 Unknown
NCT00502086 2011-02-11
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.
Catalysis SL
Phase 3 Completed
NCT00237523 2007-06-18
Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain
Symbollon Pharmaceuticals
Phase 3 Unknown